Melbourne founder Kasey Giarratana spent years struggling with health issues, including polycystic ovarian syndrome (PCOS) and endometriosis, before a naturopath urged her to take a closer look at the ingredients in her everyday beauty products.
Related Article Block Placeholder
Article ID: 338357
This personal experience and a PCOS diagnosis became the driving force behind the creation of Giarratana’s multimillion-dollar beauty brand Xali Organics, which she built from the ground up with her husband Michael Giarratana after launching it in 2022.
Xali Organics has come a long way from its first-year revenue of $13,000, with the Melbourne-based business recently revealing it has scaled to more than $20 million in revenue in under four years.
The husband-and-wife duo founded the brand with the goal of developing high-performance beauty products that women could feel confident using, without ingredients that many consumers are increasingly choosing to avoid, such as synthetic fragrance, parabens, and phthalates.
Xali Organics formulates skincare, haircare and beauty products that are vegan, cruelty-free and intentionally formulated without ingredients commonly associated with endocrine disruption concerns (EDCs).
Smarter business news. Straight to your inbox.
For startup founders, small businesses and leaders. Build sharper instincts and better strategy by learning from Australia’s smartest business minds. Sign up for free.
By continuing, you agree to our Terms & Conditions and Privacy Policy.
EDCs are chemicals that mimic, block, or interfere with hormones in the body’s endocrine system.
Since its launch, Xali Organics has sold nearly 400,000 units across its product range, including more than 190,000 units of its Lash Serum alone.
Currently, the brand has a team of 10 employees, which has doubled since January 2026. They also work with a small number of contractors and specialist partners.
Related Article Block Placeholder
Article ID: 272595
Speaking with SmartCompany, Giarratana says the growth of Xali Organics has really been a combination of conviction, calculated risk-taking, and being willing to move quickly when opportunities present themselves.
“Michael and I have bootstrapped the business entirely ourselves. We’ve never had external investors, retail distribution, or wholesale partnerships to accelerate growth. Every dollar we made is reinvested back into the business,” she says.
In order to fund the growth, the Giarratanas sold their home and put everything into growing Xali Organics.
“It was a scary decision, but we believe deeply in the brand, the products, and the opportunity we saw in the market,” Giarratana says.
“This decision meant we could invest in inventory, product development, marketing, and building the foundations of the business without relying on outside capital.”
A major turning point came in 2023 with what the Xali Organics community now refers to as the “lash chop”, which saw Giarratana cut off her lashes and document the journey of using the brand’s Lash Serum on one of her eyes vs nothing on the other.
The co-founder showed the results over eight weeks with weekly check-ins and updates on social media.
The videos quickly gained traction across social media, generating millions of views and introducing thousands of new customers to the brand.
Giarratana says another major driver of the brand’s growth has been digital marketing, particularly Meta advertising.
“From the beginning, we’ve invested heavily in creating authentic, educational, and results-focused content,” she says.
“Rather than producing traditional beauty advertising, much of our content has centred around real customer transformations, product education, founder-led storytelling, and transparent conversations about ingredients and formulations.”
Related Article Block Placeholder
Article ID: 338002
As the business grew, Giarratana says they continued reinvesting in Meta advertising because it allowed them to scale that message efficiently and helped them reach more people, but the foundation was always trust, credibility, and customer results.
“One of the advantages of operating as a digitally native brand is that we’ve been able to achieve significant scale without needing a large corporate structure,” she says.
“Through a combination of strong content, direct customer relationships, data-driven advertising and a highly engaged community, we’ve been able to build a national brand with a relatively lean team.”
Giarratana says ultimately, Xala Organic’s growth has come from creating products that genuinely solve problems and then telling those stories in a way that feels real, relatable and trustworthy.
“Rather than chasing rapid expansion through retail channels, we focused on building a direct relationship with our customers online. That allowed us to receive immediate feedback, maintain control over the customer experience, and reinvest profits back into innovation and growth,” she says.
“We’ve always taken a long-term view. Instead of raising capital, we prioritised profitability and sustainable growth. Every decision was made with the goal of building a business that could stand on its own foundations.”
Related Article Block Placeholder
Article ID: 337910
Xali Organics is now preparing for the next stage of growth, which includes a significant evolution of the brand later this year.
On the product side, the brand has multiple new launches planned across skincare, haircare and beauty, and is also exploring opportunities beyond Australia.
Giarratana added while the brand’s focus today remains direct-to-consumer, they see potential opportunities in selective retail partnerships in the future.
“If and when we enter retail, it will be with partners who align with our values and can help us introduce the brand to more customers without compromising the experience that has made Xali successful,” she says.
Note: Polycystic ovarian syndrome (PCOS) has officially been renamed polyendocrine metabolic ovarian syndrome (PMOS). This was announced on May 12 at the European Congress of Endocrinology 2026 in Prague, and the new name was published in the world-leading medical journal The Lancet.
The renaming initiative was led by Monash Centre for Health Research & Implementation director professor Helena Teede AM. PMOS affects one in eight women.